• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Orbimed founder Isaly resigns on harassment accusations

Orbimed founder Isaly resigns on harassment accusations

April 30, 2018 By Brad Perriello

OrbiMedOrbiMed founder and managing partner Sam Isaly made it official last week when he relinquished control of the private equity fund in the wake of sexual harassment allegations lodged by several former employees.

Six former employees accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and harassing women with hardcore pornography and sex toys, STAT reported Dec. 5. Isaly has denied the allegations. The sixth accuser contacted the outlet after that story, requesting anonymity for fear of reprisal by the hedge fund.

New York City-based OrbiMed said last December that Isaly would depart “pursuant to years-long succession planning discussions” and did not address the accusations from six women, first reported by STAT. OrbiMed said at the time that a committee of partners of Sven Borho, Carl Gordon and Jonathan Silverstein would take the reins from Isaly.

In a brief April 27 release, the fund again said that Isaly’s departure is the result of “ongoing succession planning” that gives ownership to the five remaining partners – Borho, Gordon, Silverstein, Carter Neild and Geoffrey Hsu.

“Mr. Isaly intends to continue to practice his investment skills as the Chief Investment Officer of the Isaly Family Office, and in other future activities, subject to his obligations to OrbiMed. Mr. Isaly thanks all of his colleagues and friends for their continued support and looks forward to many more years of investing excellence,” Orbimed said.

Yanping Ren, his sixth accuser, was a junior in college when she accepted a part-time internship at OrbiMed. Ren told STAT that Isaly routinely delivered vulgar and demeaning comments to women during her 18-month tenure, including remarks about their bodies. At least once a month, she said, she encountered women crying in the bathroom, “always related to something that happened in the office.”

“It was so normal in the company,” Ren told the site. “It was like a fact of life that everyone had to accept. Sam just did what he could get away with.”

Ren, now 29, told the outlet that she found Isaly’s conduct and its lack of consequences shocking. As her first experience in the world of finance, she assumed it was the norm.

“In college, you kind of hear about how crazy the workplace can be,” Ren said. “So I thought, ‘Oh this is just how it is.’”

Luckily her next job, at Vatera, was the opposite, where her boss was a woman and the culture was one of professionalism and respect, she said.

Although the fund did not respond to questions about Ren’s account, in a statement it said it “takes gender equality seriously and wishes to encourage a supportive work environment and equal opportunity for all employees.”

“When I read that statement, I found it quite funny,” Ren told STAT, “because it’s so far from the truth.”

Filed Under: Wall Street Beat Tagged With: OrbiMed, Personnel Moves, Venture Capital/Private Equity

More recent news

  • Abbott sets Libre Duo glucose-ketone sensor US launch for December
  • Edwards wins FDA approval for Pascal Precision in tricuspid valve repair
  • Danaher’s Masimo acquisition offsets drops in respiratory diagnostic sales
  • Intuitive stock slides as US procedures slow amid $450M settlement
  • Abbott to spin out Nutrition business, cuts guidance

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy